DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

Karl Wurstbauer; Heinz Deutschmann; Karin Dagn; Peter Kopp; Franz Zehentmayr; Bernd Lamprecht; Peter Porsch; Birgit Wegleitner; Michael Studnicka; Felix Sedlmayer

doi:10.1186/1748-717X-8-49

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

Karl Wurstbauer^* (First author), Heinz Deutschmann (Co-author), Karin Dagn, Peter Kopp, Franz Zehentmayr (Co-author), Bernd Lamprecht, Peter Porsch, Birgit Wegleitner, Michael Studnicka (Co-author), Felix Sedlmayer (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

15 Citations (Web of Science)

Original language	English
Pages (from-to)	49
Journal	RADIATION ONCOLOGY
Volume	8
DOIs	https://doi.org/10.1186/1748-717X-8-49
Publication status	Published - 2013

Keywords

CELL LUNG-CANCER
PHASE-III TRIAL
TERM-FOLLOW-UP
INDUCTION CHEMOTHERAPY
THORACIC RADIOTHERAPY
ONCOLOGY-GROUP
I/II TRIAL
STAGES I
CONCURRENT
ESCALATION

Access to Document

10.1186/1748-717X-8-49

Cite this

Wurstbauer, K., Deutschmann, H., Dagn, K., Kopp, P., Zehentmayr, F., Lamprecht, B., Porsch, P., Wegleitner, B., Studnicka, M., & Sedlmayer, F. (2013). DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume. RADIATION ONCOLOGY, 8, 49. https://doi.org/10.1186/1748-717X-8-49

@article{1579554c5bc84b0abd8f15ae7321456c,

title = "DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume",

keywords = "CELL LUNG-CANCER, PHASE-III TRIAL, TERM-FOLLOW-UP, INDUCTION CHEMOTHERAPY, THORACIC RADIOTHERAPY, ONCOLOGY-GROUP, I/II TRIAL, STAGES I, CONCURRENT, ESCALATION",

author = "Karl Wurstbauer and Heinz Deutschmann and Karin Dagn and Peter Kopp and Franz Zehentmayr and Bernd Lamprecht and Peter Porsch and Birgit Wegleitner and Michael Studnicka and Felix Sedlmayer",

note = " Karl Wurstbauer1,3*, Heinz Deutschmann1, Karin Dagn1, Peter Kopp1, Franz Zehentmayr1, Bernd Lamprecht2, Peter Porsch2, Birgit Wegleitner2, Michael Studnicka2 and Felix Sedlmayer1 * Corresponding author: Karl Wurstbauer [email protected] 1 Department of Radiation Oncology and radART-Institute for research and development on Advanced Radiation Technologies, Paracelsus Medical University, Salzburg, Austria 2 Department of Pneumology, Paracelsus Medical University, Salzburg, Austria 3 Universit{\"a}tsklinik f{\"u}r Radiotherapie, M{\"u}llner Hauptstrasse 48, Salzburg, A-5020, Austria ",

year = "2013",

doi = "10.1186/1748-717X-8-49",

language = "English",

volume = "8",

pages = "49",

journal = "RADIATION ONCOLOGY",

issn = "1748-717X",

publisher = "Springer Nature",

}

Wurstbauer, K, Deutschmann, H, Dagn, K, Kopp, P, Zehentmayr, F, Lamprecht, B, Porsch, P, Wegleitner, B, Studnicka, M & Sedlmayer, F 2013, 'DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume', RADIATION ONCOLOGY, vol. 8, pp. 49. https://doi.org/10.1186/1748-717X-8-49

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume. / Wurstbauer, Karl (First author); Deutschmann, Heinz (Co-author); Dagn, Karin et al.
In: RADIATION ONCOLOGY, Vol. 8, 2013, p. 49.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

AU - Wurstbauer, Karl

AU - Deutschmann, Heinz

AU - Dagn, Karin

AU - Kopp, Peter

AU - Zehentmayr, Franz

AU - Lamprecht, Bernd

AU - Porsch, Peter

AU - Wegleitner, Birgit

AU - Studnicka, Michael

AU - Sedlmayer, Felix

N1 - Karl Wurstbauer1,3*, Heinz Deutschmann1, Karin Dagn1, Peter Kopp1, Franz Zehentmayr1, Bernd Lamprecht2, Peter Porsch2, Birgit Wegleitner2, Michael Studnicka2 and Felix Sedlmayer1 * Corresponding author: Karl Wurstbauer [email protected] 1 Department of Radiation Oncology and radART-Institute for research and development on Advanced Radiation Technologies, Paracelsus Medical University, Salzburg, Austria 2 Department of Pneumology, Paracelsus Medical University, Salzburg, Austria 3 Universitätsklinik für Radiotherapie, Müllner Hauptstrasse 48, Salzburg, A-5020, Austria

PY - 2013

Y1 - 2013

KW - CELL LUNG-CANCER

KW - PHASE-III TRIAL

KW - TERM-FOLLOW-UP

KW - INDUCTION CHEMOTHERAPY

KW - THORACIC RADIOTHERAPY

KW - ONCOLOGY-GROUP

KW - I/II TRIAL

KW - STAGES I

KW - CONCURRENT

KW - ESCALATION

U2 - 10.1186/1748-717X-8-49

DO - 10.1186/1748-717X-8-49

M3 - Original Article

C2 - 23497555

SN - 1748-717X

VL - 8

SP - 49

JO - RADIATION ONCOLOGY

JF - RADIATION ONCOLOGY

ER -